Status:
COMPLETED
Mean Platelet Volume and Its Relation to Risk Stratification of Myelodysplastic Syndromes
Lead Sponsor:
Assiut University
Conditions:
Myelodysplastic Syndromes
Eligibility:
All Genders
18+ years
Brief Summary
The myelodysplastic syndromes (MDS) are a group of myeloid neoplasms characterized by abnormal differentiation and maturation of myeloid cells, reduced bone marrow (BM) function, and a genetic instabi...
Detailed Description
The diagnosis of MDS is an effort that requires clinicians and pathologists to work together. A patient's life, livelihood and outlook can be profoundly affected by the terms used by the treating phys...
Eligibility Criteria
Inclusion
- All patients diagnosed to have myelodysplastic syndromes
Exclusion
- no
Key Trial Info
Start Date :
October 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT05204953
Start Date
October 1 2013
End Date
April 1 2015
Last Update
January 24 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.